Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus morphine for agitation after cardiac surgery
IRCT20190325043107N52Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in agitation comparing Dexmedetomidine infusion with Morphine infusion (2 arms). Primary endpoint: Agitation. Started Jul 2022; status: completed.
02
Drugs
dexmedetomidinemorphine
03
Conditions
agitation
Beyond the preview
Go deeper on IRCT20190325043107N52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N52.